Navigation Links
IFRS Information - First Half of 2007
Date:9/13/2007

141.8 - 141.8

Short-term investments 55.8 - 55.8

Cash and cash equivalents 74.9 - 74.9

Non-current liabilities:

Sold warrants (133.0) 133.0 -

Deferred income, non-current (59.5) 59.5 -

Deferred tax liability,

non-current (1.1) (1,202.4) (1,203.5)

Current liabilities:

Convertible loan notes (279.4) - (279.4)

Accounts payable and accrued

expenses (33.3) 1.6 (31.7)

Deferred income, current (3.1) 3.1 -

Accrued share based payment

liability (122.9) 122.9 -

_____________ _____________ _____________

Net assets acquired at fair

value (348.6) 2,252.7 1,904.1

Goodwill 689.8

_____________ _____________ _____________

2,593.9

Total consideration satisfied

by:

Cash (including $60.4 million of

direct costs of acquisition) 2,593.9

_____________ _____________ _____________

(1) Apart from the inclusion of the convertible loan notes,

the purchased call option and sold warrants according to IAS 32

"Financial Instruments: Presentation" and IAS 39 "Financial

Instruments: Recognition and Measurement" in the book value of net

liabilities acquired, the remaining book values as presented above

are stated as under US GAAP and have not been restated to IFRS on'/>"/>

SOURCE Shire plc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Imaging and Analysis of DIGE Product Information Sheet, Rev B
2. Study affirms information technology-productivity link
3. TrafficCast integrates new information source
4. Rote education fails the Information Age
5. Weather information companies launch data product
6. TeraMedica launches information manager
7. Global information firm reaches diverse markets
8. Preparing for avian flu with information technology
9. Businesses cant hide personal information losses, theft
10. S.C. Johnson lands in No. 2 spot in Information Week 500 list
11. Crate and Barrel deploys Firstlogics Information Quality Suite
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... , July 3, 2015  Pomerantz LLP announces ... Puma Biotechnology, Inc. ("Puma" or the "Company")(NYSE: PBYI ... filed in United States District Court, Central District of ... is on behalf of a class consisting of all ... 23, 2014 and May 13, 2015 inclusive (the "Class ...
(Date:7/2/2015)... Amici Procurement Migrates to the ... Procurement has chosen Microsoft Cloud Solution Provider iomart ... 365.      (Logo: http://photos.prnewswire.com/prnh/20121126/579634) , ... in the bio-tech sector with a unique procurement service, ... to help them obtain best value. Its IT platform ...
(Date:7/1/2015)...   Decision Resources Group finds that ... are its oral administration, alternative mechanism of action, ... rheumatologists. Otezla was the first oral therapy specifically ... psoriatic arthritis in the United States ... conventional oral treatments including disease-modifying antirheumatic drugs (DMARDs), ...
(Date:7/1/2015)... Ariz. , July 1, 2015 Isagenix ... it has earned three Gold, three Silver, and three ... Awards gala held in Chicago ... as the premier business awards program in the U.S. ... recognizes our company,s strength in developing leaders, cultivating talent, ...
Breaking Biology Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 2SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 3SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 4Biotech Procurement Company Moves to Office 365 with iomart 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Isagenix Earns Nine American Business Awards 2Isagenix Earns Nine American Business Awards 3
... ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ), a biopharmaceutical ... candidates for the treatment,of cancer and infectious diseases, ... officer is scheduled to present at the 20th,Annual ... 2007,at 8:30 a.m. Eastern Daylight Time. The conference ...
... the Phase III Clinical Development and ... of THR-100 in Developing Countries, LEUVEN, Belgium, ... biotechnology company focused on vascular disease, today,announced the ... International Limited (Hyderabad, India) for the manufacture of,THR-100, ...
... Inc. (the "Company") (Nasdaq: CMED ), a leading China-based,medical ... products and high intensity focused ultrasound tumor,therapy systems, today announced ... - China Day. Location: ... ...
Cached Biology Technology:ADVENTRX Pharmaceuticals to Present at the 20th Annual Bear Stearns Healthcare Conference 2ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 2ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 3ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 4
(Date:6/24/2015)... 22, 2015 Research ... of the "Huawei Ascend Mate 7 Fingerprint ... their offering. Huawei,s technological choice for ... direction than Apple,s and Samsung,s one. The Ascend ... by Fingerprint Cards, a main actor in capacitive ...
(Date:6/23/2015)... , June 23, 2015   MedNet ... that supports the entire spectrum of clinical research, ... ™ , the company,s intuitive, flexible ... awarded a Silver 2015 Stevie® Award by the ... Products & Services Website category.  The American Business ...
(Date:6/23/2015)... , June 23, 2015   Valencell, ... announced the results of a recent study that ... on the wrist during activity. In a study ... was compared along with the Apple Watch against ... measuring heart rate during activity. The study demonstrated ...
Breaking Biology News(10 mins):Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
... with a Star Trek twist, at the U.S. Department ... Determining who needs medical care at the scene ... bent over a victim, checking body temperature, heart rate, ... entire process can take 3-5 minutes per person. ...
... a "Dream Team." Lombardi Comprehensive Cancer Center,s ... and 12 of the nation,s top breast cancer researchers ... Up To Cancer (SU2C) to form a scientific "Dream ... brightest scientists will conduct new breast cancer research with ...
... Rice University researchers today announced that the first ... technology for removing arsenic from drinking water, will ... "Mexico,s debating the adoption of more stringent national ... water, and officials in Guanajuato are looking ahead ...
Cached Biology News:Triage technology with a Star Trek twist 2Lombardi scientist brings 'dream team' breast cancer research effort to GUMC 2Lombardi scientist brings 'dream team' breast cancer research effort to GUMC 3First 'nanorust' field test slated in Mexico 2
... in the Microsart e.motion are sterile-sealed, without protective ... specially designed individual package on a band. ... membrane filter units ensures that they are perfectly ... band guarantees uniform dispensing of the individual membrane ...
...
These 22x40mm rectangular No.1 Corning cover glasses are made from No. 0211 zinc titania glass and are 0.16 to 0.19mm thick. • Approx. Pcs Oz : 73...
The model 55D Rocking Shaker provides the same Reliable quality as the 55S, but double the value. The 55D gives you an additional platform with a height of 3.25 in....
Biology Products: